Basel is one of the world's most concentrated pharmaceutical and life-sciences hubs, home to global R&D campuses, clinical development functions, and a dense executive population that has spent its career inside a science-driven industry. For this group, an annual check-up with a general practitioner (Hausarzt) is a reasonable baseline. It is rarely built for the specific risk profile that comes with decades of high-stakes decision-making, frequent long-haul travel, and a professional fluency in reading clinical data that most patients simply do not have.
This article looks at why executive health screening in Basel's pharma and life-sciences sector deserves a more tailored approach, and what that approach should actually measure.
Why Basel's pharma and life-sciences executives are a distinct risk group
Executives and senior scientists in Basel's pharmaceutical and life-sciences sector share occupational patterns that rarely show up in a generic over-40 check-up template:
- Long, specialised careers. Many have spent fifteen to thirty years in R&D, regulatory, or executive functions, often starting in the lab and moving into leadership. That length and intensity of exposure to lab environments, irregular hours, and desk-bound leadership work compounds differently than a typical career.
- Frequent international travel. Regular travel between Basel and hubs such as Boston, New Jersey, Singapore, or Shanghai disrupts sleep architecture and circadian rhythm, and, over years, can influence metabolic and cardiovascular regulation.
- High-stakes decision-making. Portfolio decisions, regulatory submissions, and board-level accountability sustain a chronic, low-grade stress load that is well documented to interact with cortisol regulation, inflammatory markers, and blood pressure over time.
- An unusually well-informed audience. This population reads clinical and trial data professionally. A screening report that simply states "normal" without the underlying values, reference ranges, and year-over-year trend lines under-serves people who interrogate data for a living.
What a standard GP check typically does not cover
A routine Hausarzt check-up is a valuable baseline: total cholesterol, fasting glucose, blood pressure, basic liver and kidney function. For an executive population with the profile above, several categories of longer-term risk markers are often left out, simply because they sit outside the standard panel rather than because they are exotic:
- Cardiovascular markers beyond total cholesterol, such as particle-level lipid markers and inflammatory markers like hs-CRP, which add resolution that total cholesterol alone does not provide.
- Metabolic markers, such as fasting insulin and HbA1c trends, which can flag early insulin resistance years before fasting glucose alone would.
- Hormonal panels, including full thyroid function and, where relevant, sex hormones and cortisol patterns, all of which shift with age, travel load, and chronic stress.
- Inflammatory and nutritional markers, such as homocysteine, vitamin D, B12, ferritin, and omega-3 status, frequently affected by travel-heavy schedules and irregular diets.
None of this replaces a physician relationship or a diagnosis. It is a broader data set, reviewed by a physician, that gives a more complete picture of long-term cardiovascular, metabolic, hormonal, and nutritional trends.
How Aeonix approaches executive screening
Aeonix is a Swiss direct-access preventive blood-screening service, built around three things this audience tends to value: precision, discretion, and time efficiency.
- No referral required. You book directly, without first securing an appointment with a GP.
- Blood only, by design. No MRI, no radiation, no claustrophobia: a single blood draw at a Swiss partner lab (the Viollier, Unilabs, or Synlab network), fitting into a lunch break rather than a half-day clinic visit.
- Results in 48 hours. Physician-reviewed and delivered through a secure digital dashboard, considerably faster than the four-to-five-week waits reported for some other Swiss screening providers.
- Annual tracking. Aeonix runs on a yearly subscription rather than a one-off test, so your biomarkers are tracked year over year. For a long career, the trend line matters more than any single snapshot.
- Swiss data handling. Data is stored in Switzerland, under GDPR and nDSG (Swiss data protection law).
Frequently asked questions
Is Aeonix the same company as Aeon? No. Aeonix and Aeon (aeon.life) are two separate, unrelated companies. Aeonix is operated by AllesHealth GmbH and offers blood-only preventive screening on an annual subscription model, with results in 48 hours.
Will my health insurance cover this? Swiss basic insurance (KVG) does not cover preventive blood screening for healthy adults, and Aeonix does not bill insurers directly or offer reimbursement. Some supplementary (VVG) plans include a prevention budget that may cover part of the cost, so it is worth checking your own policy. You will receive a detailed receipt you can submit yourself.
Do I need a referral from my doctor? No. Aeonix is direct-access, so you can book without a GP referral. Your blood is drawn at a Swiss partner lab, and your results are reviewed by a physician before being released to you.
How long does it take to get results? Physician-reviewed results are delivered digitally within 48 hours of your blood draw.
Plans and pricing
Aeonix offers four annual plans, scaled by age band and panel depth. 100+–150+ biomarkers depending on plan.
| Plan | Age band | Markers | Domains | Price |
|---|---|---|---|---|
| Prime Health | 25–45 | 100+ | 10–11 | CHF 595/year |
| Vital Edge | 35–55 | 125+ | 12–13 | CHF 795/year |
| Longevity Plus | 55–65 | 135+ | 13–14 | CHF 995/year |
| Elite | 65+ | 150+ | 14–15 | CHF 1,295/year |
All plans include: renowned Swiss lab · physician-reviewed results · secure dashboard · annual tracking · support DE/EN/FR/IT.